Where is the live CopyMark page for USPTO serial 79097063?

The live record is at https://getcopymark.com/trademark/79097063. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns CUREA MEDICAL INNOVATION WITH CARE?

According to the public USPTO record for serial number 79097063, the listed owner(s) include: McAirlaid's Vliesstoffe GmbH, McAirlaid's Vliesstoffe GmbH & Co. KG, McAirlaid's Vliesstoffe GmbH & Co. KG, McAirlaid's Vliesstoffe GmbH & Co. KG, curea medical GmbH.

What is USPTO serial number 79097063?

Serial number 79097063 is the USPTO application identifier for the mark CUREA MEDICAL INNOVATION WITH CARE. It is used to track examination, publication, and registration of this trademark.

What is the current status of CUREA MEDICAL INNOVATION WITH CARE?

CUREA MEDICAL INNOVATION WITH CARE (79097063) currently shows USPTO status code 706 on the public record. This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Which trademark classes cover CUREA MEDICAL INNOVATION WITH CARE?

The public record lists International Classes: 005, 010, 027. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: CUREA MEDICAL INNOVATION WITH CARE Serial# 79097063 Reg# 4140768 | Registered USPTO trademark | status 706; last event NREP | Trademark Info & Attorney Guidance

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CUREA MEDICAL INNOVATION WITH CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Moskowitz

Max Moskowitz Ostrolenk Faber LLP845 THIRD AVENUE, 8th FloorNew York, NY 10022UNITED STATES

Goods and services

Class	Description	Status	First use
005	Sanitary preparations for medical use; [ medical plasters, ] medical dressings [ ; pharmaceutical preparations for wound treatment, namely, absorbent and implantable haemostatic agents and preparations; ] [ medicated skin care preparations; ] [ preparations for removing plasters, medical dressing materials, and residue of the aforementioned plasters and dressing materials, namely, rubbing alcohol ]	ACTIVE	—
010	[ Surgical and medical instruments for use in general surgery, namely, suture materials; ] draw-sheets for sick beds; incontinence sheets; incontinence bed pads for absorbing bodily fluids	ACTIVE	—
027	Floor mats	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
May 16, 2025	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Jul 18, 2024	CHLD	CHANGE OF OWNER RECEIVED FROM IB	—
Mar 3, 2024	INNP	PARTIAL INVALIDATION PROCESSED BY THE IB	—
Feb 7, 2024	INPS	PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Feb 7, 2024	INPC	INVALIDATION PROCESSED	—
Jan 31, 2024	INPR	PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED	—
May 31, 2023	NA71	NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	—
May 31, 2023	71AG	REGISTERED-SEC.71 ACCEPTED	—
May 26, 2023	EROP	TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED	—
May 20, 2023	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Dec 22, 2022	PR71	POST REGISTRATION ACTION MAILED - SEC.71	—
Oct 25, 2022	PR71	POST REGISTRATION ACTION MAILED - SEC.71	—
Oct 25, 2022	PR71	POST REGISTRATION ACTION MAILED - SEC.71	—
Oct 24, 2022	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
May 10, 2022	ES71	TEAS SECTION 71 RECEIVED	—
Apr 28, 2022	CORN	CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED	—
Mar 20, 2022	CRCV	CORRECTION TRANSACTION RECEIVED FROM IB	—
Mar 11, 2022	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Mar 4, 2022	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Nov 12, 2021	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
May 15, 2021	REM4	COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED	—
Mar 5, 2021	RNWL	INTERNATIONAL REGISTRATION RENEWED	—
Mar 20, 2020	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Nov 11, 2018	NA75	NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED	—
Nov 11, 2018	C75A	REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.	—
Nov 1, 2018	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Oct 11, 2018	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Oct 10, 2018	EROP	TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED	—
May 29, 2018	PR75	POST REGISTRATION ACTION MAILED - SEC. 71 & 15	—
May 15, 2018	EROP	TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED	—
Dec 14, 2017	PR75	POST REGISTRATION ACTION MAILED - SEC. 71 & 15	—
Dec 13, 2017	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Nov 20, 2017	ES75	TEAS SECTION 71 & 15 RECEIVED	—
May 15, 2017	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Dec 4, 2014	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Jun 5, 2014	CHLD	CHANGE OF OWNER RECEIVED FROM IB	—
Nov 25, 2012	GPNX	NOTIFICATION PROCESSED BY IB	—
Sep 9, 2012	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Aug 17, 2012	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Aug 17, 2012	FIMP	FINAL DISPOSITION PROCESSED	—
Aug 15, 2012	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
May 15, 2012	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 28, 2012	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Feb 28, 2012	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2012	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Feb 8, 2012	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Feb 8, 2012	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Jan 25, 2012	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Jan 18, 2012	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jan 18, 2012	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Jan 18, 2012	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Dec 19, 2011	ALIE	ASSIGNED TO LIE	—
Dec 15, 2011	MAIL	PAPER RECEIVED	—
Dec 9, 2011	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2011	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Jun 28, 2011	RFNT	REFUSAL PROCESSED BY IB	—
Jun 9, 2011	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jun 8, 2011	RFRR	REFUSAL PROCESSED BY MPU	—
Jun 8, 2011	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Jun 7, 2011	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2011	MAFR	APPLICATION FILING RECEIPT MAILED	—
Jun 3, 2011	DOCK	ASSIGNED TO EXAMINER	—
Jun 3, 2011	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jun 2, 2011	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

CUREA MEDICAL INNOVATION WITH CARE